Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Angitia raises $130M to advance bone-building bispecifics
Angitia's second mega-round in 14 months will support phase 2 and 3 clinical trials of three bone disease prospects.
Nick Paul Taylor
Feb 5, 2026 10:17am
Fierce Biotech Fundraising Tracker '26: Angitia & more
Feb 5, 2026 9:30am
Quell halts transplant trial to focus on 'chill not kill' Treg
Feb 5, 2026 6:00am
Santé Ventures closes $330M fund for biotech, medtech and more
Feb 2, 2026 8:15am
European investment firm ends activity in the life sciences
Jan 26, 2026 2:25pm
Fortitude has faith glue degraders can beat ADC resistance
Jan 26, 2026 10:47am
